According to Ocuphire Pharma's latest financial reports the company's current EPS (TTM) is $0.89. In 2022 the company made an earnings per share (EPS) of $0.81 an increase over its 2021 EPS that were of -$4.69.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.89 | 9.88% |
2022 | $0.81 | -117.27% |
2021 | -$4.69 | 83.63% |
2020 | -$2.55 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.27 | -130.34% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$1.00 | -212.36% | ๐บ๐ธ USA |